MarkStevenCohenMDFACS, FSSO
General Surgery • Urbana, ILEndocrine, Melanoma, Surgical Oncology (Other than Breast)
Dean, Carle Illinois College of Medicine University of Illinois, Urbana-Champaign Senior Vice President and Chief Academic Officer, Carle Health
Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Medical Sciences Building
506 South Mathews Avenue | M/C 325
Urbana, IL 61801Phone+1 217-300-5700
Summary
- Dr. Mark Cohen is a nationally recognized surgeon in Urbana IL at Carle Health where he the SVP and CAO and serves as Dean of the Carle Illinois College of Medicine. He received his MD from Wash U St. Louis and has been in practice since 2006. He specializes in surgical oncology and endocrine surgery including minimally invasive thyroid and parathyroid procedures, and advanced melanoma surgery.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1998 - 2006- Washington University in St. Louis School of MedicineClass of 1998
Certifications & Licensure
IL State Medical License 2022 - 2026
MI State Medical License 2012 - 2025
MO State Medical License 2000 - 2014
KS State Medical License Active through 2013- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 790 citationsSimultaneous EEG and fMRI of the alpha rhythm.Robin I. Goldman, John M. Stern, Jerome Engel, Mark S. Cohen
Neuroreport. 2002-12-20 - 93 citationsInsights into multimodal imaging classification of ADHD.John B. Colby, Jeffrey D. Rudie, Jesse A. Brown, Pamela K. Douglas, Mark S. Cohen
Frontiers in Systems Neuroscience. 2012-08-16 - 113 citationsOld and New Approaches to Target the Hsp90 ChaperoneJackee N Sanchez, Trever R. Carter, Mark S. Cohen, Brian S. J. Blagg
Current Cancer Drug Targets. 2020-01-01
Journal Articles
- Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification SystemM S Cohen, D T Hughes, B S Miller, P G Gauger, R J Auchus, World Journal of Surgery
Press Mentions
How Is AI Changing Health Care?October 4th, 2024- U Michigan Health to Tap Mixed Reality for Student Clinical PracticeDecember 20th, 2021
- Applying Extended Reality Technologies to RoundsFebruary 5th, 2021
- Join now to see all
Grant Support
- Optimization and Investigation of Cruentaren A AnalogsNIH/NCI2018–Present
- New Paradigms for Hsp90 InhibitionNIH/NCI2017–Present
- Development and Evaluation of Purine and Coumarin Based HSP90 InhibitorsNIH/NCI2015–Present
Committees
- Co-Chair, Membership Committee AAS 2014 - Present
- Chair, Program Committee AAES 2012 - 2013
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Amercian Surgical Association - ASAMember
- Society of University Surgeons - SUSMember
- Southwestern Surgical Congress -SWSCMember
- American Association of Endocrine Surgeons - AAESMember
- Asian Association of Endocrine Surgeons - AsAESMember
- International Association of Endocrine Surgeons - IAESMember
- International Society of Surgery - ISSMember
- American Medical Association - AMAMember
- American Association for the Advancement of Science - AAASMember
- American Association for Cancer Research - AACRMember
External Links
- Linked-Inhttp://linkedin.com/in/cohen-mark-a5001414a
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
